Alnylam Pharmaceuticals
ALNY
#447
Rank
NZ$90.06 B
Marketcap
NZ$681.74
Share price
-2.21%
Change (1 day)
58.90%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company